What Makes Penumbra (PEN) a Good Investment Choice?

6 days ago 4

Soumya Eswaran

Tue, March 17, 2026 astatine 8:58 AM CDT 3 min read

Artisan Partners, an concern absorption company, released its fourth-quarter 2025 capitalist missive for “Artisan Small Cap Fund”. A transcript of the missive tin beryllium downloaded here. The Fund seeks to put successful companies that person franchise characteristics, with beardown net trajectories, and are trading astatine a discount to the estimated backstage marketplace value. Despite beardown results successful 2025, volatility was elevated, and sentiment shifted frequently, influenced by governmental developments successful the US, evolving commercialized argumentation rhetoric, changing expectations for monetary policy, and ongoing geopolitical tensions. Against this backdrop, the Fund posted beardown implicit returns successful the 4th quarter, outperforming some the Russell 2000® Growth Index and the Russell 2000® Index. The portfolio delivered beardown results successful the 4th crossed each segments. In contrast, for the afloat year, the Fund generated beardown results but trailed some the indexes. In Q4 2025, the marketplace enactment shifted backmost to companies with durable nett cycles. Moving to 2026, the steadfast continues to absorption connected its proven method of identifying nett cycles successful franchise companies astatine tenable valuations. Please reappraisal the Fund’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Artisan Small Cap Fund highlighted stocks similar Penumbra, Inc. (NYSE:PEN). Penumbra, Inc. (NYSE:PEN) is simply a aesculapian instrumentality shaper that offers peripheral thrombectomy products. On March 16, 2026, Penumbra, Inc. (NYSE:PEN) banal closed astatine $336.21 per share. One-month instrumentality of Penumbra, Inc. (NYSE:PEN) was -1.41%, and its shares are up 22.13% implicit the past 12 months. Penumbra, Inc. (NYSE:PEN) has a marketplace capitalization of $13.194 billion.

Artisan Small Cap Fund stated the pursuing regarding Penumbra, Inc. (NYSE:PEN) successful its 4th fourth 2025 capitalist letter:

"We besides added to Bruker, Hexcel and Penumbra, Inc. (NYSE:PEN) during the quarter. Penumbra is simply a aesculapian instrumentality institution focused connected minimally invasive treatments for removing humor clots and treating vascular conditions specified arsenic stroke, aneurysms and pulmonary embolism. We added to the presumption arsenic adoption of its halfway products grows, supported by beardown objective outcomes, a favorable information illustration and broader usage by physicians beyond neurologists. The institution is besides benefiting from competitory disruption and a maturing, much specialized income force, portion upcoming regulatory approvals for next-generation devices could further accelerate its nett cycle."

Read Entire Article